MS
Therapeutic Areas
Relmada Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NDV-01 | Non-Muscle Invasive Bladder Cancer (NMIBC) | Phase 2/3 |
| Sepranolone | Prader-Willi Syndrome (compulsive behaviors/hyperphagia) | Phase 2b-ready |
| Drug | Indication | Phase |
|---|---|---|
| NDV-01 | Non-Muscle Invasive Bladder Cancer (NMIBC) | Phase 2/3 |
| Sepranolone | Prader-Willi Syndrome (compulsive behaviors/hyperphagia) | Phase 2b-ready |